AEPCX
Price
$58.16
Change
+$0.03 (+0.05%)
Updated
Jun 5 closing price
Net Assets
133.45B
BGITX
Price
$14.96
Change
+$0.03 (+0.20%)
Updated
Jun 5 closing price
Net Assets
2.31B
Interact to see
Advertisement

AEPCX vs BGITX

Header iconAEPCX vs BGITX Comparison
Open Charts AEPCX vs BGITXBanner chart's image
American Funds EUPAC C
Price$58.16
Change+$0.03 (+0.05%)
VolumeN/A
Net Assets133.45B
Baillie Gifford International Alpha 2
Price$14.96
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets2.31B
AEPCX vs BGITX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. BGITX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and BGITX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. BGITX (2.31B). BGITX pays higher dividends than AEPCX: BGITX (0.65) vs AEPCX (0.32). AEPCX was incepted earlier than BGITX: AEPCX (24 years) vs BGITX (17 years). AEPCX (1.59) is less costly to investors than BGITX (0.59). AEPCX is a more actively managed with annual turnover of: 30.00 vs. BGITX (20.00). AEPCX has a lower initial minimum investment than BGITX: AEPCX (250) vs BGITX (25000000). BGITX annual gain was more profitable for investors over the last year : 11.43 vs. AEPCX (2.04). BGITX return over 5 years is better than : 17.60 vs. AEPCX (14.22).
AEPCXBGITXAEPCX / BGITX
Total Expense Ratio1.590.59269%
Annual Report Gross Expense Ratio1.590.59269%
Fund Existence24 years17 years-
Gain YTD12.50217.09973%
Front LoadN/AN/A-
Min. Initial Investment250250000000%
Min. Initial Investment IRAN/AN/A-
Net Assets133B2.31B5,748%
Annual Yield % from dividends0.320.6550%
Returns for 1 year2.0411.4318%
Returns for 3 years14.8231.1848%
Returns for 5 years14.2217.6081%
Returns for 10 years20.6744.2647%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SNN30.301.03
+3.52%
Smith & Nephew plc
APLS19.100.59
+3.19%
Apellis Pharmaceuticals
CATO2.63-0.01
-0.38%
CATO Corp
STOK10.86-0.08
-0.73%
Stoke Therapeutics
GRI1.39-0.06
-4.14%
GRI Bio Inc.